KERRI MCDONALD: Open Payments
NPI 1154872364 · HAVRE DE GRACE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,775 in 88 payments from 16 companies in 2025. Trend: 2023 $2,264 · 2024 $1,865 · 2025 $1,775
Food & beverage: $1,775
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 22 | $364 |
| UCB, Inc. | 17 | $350 |
| Regeneron Healthcare Solutions, Inc. | 8 | $270 |
| ABBVIE INC. | 8 | $162 |
| GENZYME CORPORATION | 4 | $132 |
| Janssen Biotech, Inc. | 4 | $106 |
| Organon LLC | 11 | $95 |
| PFIZER INC. | 4 | $77 |
| Sandoz Inc. | 2 | $55 |
| LEO Pharma Inc. | 2 | $51 |
Products named: DUPIXENT, Bimzelx, COSENTYX, SKYRIZI, TREMFYA, CIBINQO, Rhapsido, HYRIMOZ.
Industry payments across MD — which companies pay providers there.
